Abirapro 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Abirapro 250 mg Tablet

Abirapro 250 mg Tablet

Abirapro 250 mg Tablet contains abiraterone acetate 250 mg and is an oral hormonal anticancer medicine used in the treatment of advanced prostate cancer. It is taken on an empty stomach according to the treatment plan prescribed by the oncologist. Abiraterone reduces androgen production by inhibiting CYP17, helping limit hormone-driven prostate cancer growth.

BUY NOW

Category

Abirapro is an androgen biosynthesis inhibitor used as part of appropriate treatment regimens for advanced prostate cancer. It suppresses androgen production in the testes, adrenal glands, and prostate tumor tissue by inhibiting the CYP17 enzyme. Abiraterone therapy is generally used with prednisone or prednisolone as directed by the treating physician to manage treatment-related mineralocorticoid effects. During treatment, monitoring of blood pressure, serum potassium, liver function, and fluid retention may be required.

Technical Specification

Specification Details
Active Ingredient Abiraterone Acetate
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Antineoplastic
Marketer Glenmark Pharmaceuticals Ltd

Product Also Known As

Abirapro 250mg Tablet, Abirapro 250 mg Tablet, Abiraterone Acetate 250mg Tablet, Abiraterone 250mg Tablet, Abiraterone Acetate Tablet 250mg, Abiraterone Prostate Cancer Tablet